From the March 27, 2020, edition of Fox Business' Mornings with Maria Bartiromo

MARIA BARTIROMO (ANCHOR): So are you -- so do you think that a treatment will be on the market over the near term? And what's your take, for example, on this antimalaria drug being used to treat coronavirus? When would you expect some of these antivirals on the market, Dr. Oz?

DR. MEHMET OZ: Well, I had the opportunity to ask Vice President Pence that at a town hall earlier this week, and he said he was pleased that the FDA was going to allow these products to be used by doctors as they desire. It's already approved for use in malaria, rheumatoid arthritis, lupus, I mean a bunch of conditions that do benefit from hydroxychloroquine. But here’s the big thing: We don't have double-blind, randomized data the kind the FDA needs to make decisions on these products. In that particular case, the antimalarial drug is used in China. It’s actually part of their strategy for treating coronavirus. But we've never seen, at least I haven't seen, I've looked pretty aggressively for randomized data. I did have the French physician on, Didier Raoult who did the pioneering work in France. He's very well respected there, and they're using it in some centers now. And it worked for him. He was able to reduce the levels of virus.

BARTIROMO: I love that you had him on.